Interferon Beta-1b
1 NDC across 1 manufacturer|0 Generic,1 Brand
Interferon Beta-1b is used to treat brain neoplasms, hepatocellular carcinoma, renal cell carcinoma, colorectal neoplasms, cryoglobulinemia and hemangioma, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $93 million on Interferon Beta-1b across 9,209 claims for 1,073 beneficiaries.
Interferon Beta-1b is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $725.97 to $725.97 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$725.97 – $725.97
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing INTERFERON BETA-1B
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BETASERON 0.3 MG KIT | $725.9747 per EA | — |
Frequently Asked Questions
What is Interferon Beta-1b used to treat?
Interferon Beta-1b is used to treat brain neoplasms, hepatocellular carcinoma, renal cell carcinoma, colorectal neoplasms, cryoglobulinemia and hemangioma, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Interferon Beta-1b?
In 2024, Medicare Part D spent $93 million on Interferon Beta-1b across 9,209 claims for 1,073 beneficiaries.
How many Interferon Beta-1b products are on the market?
The Interferon Beta-1b drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Interferon Beta-1b?
NADAC reference prices for Interferon Beta-1b range from $725.9747 to $725.9747 per EA.
Which manufacturers make Interferon Beta-1b?
1 manufacturer lists Interferon Beta-1b in NADAC. Ranked by number of NDCs, the largest are Bayer HealthCare Pharmaceuticals Inc. (1).